Trudeau M - Search Results

1

Cost-effectiveness Analysis of Pertuzumab With Trastuzumab in Patients With Metastatic Breast Cancer.

Dai WF, Beca JM, Nagamuthu C, Liu N, de Oliveira C, Earle CC, Trudeau M, Chan KKW. Dai WF, et al. Among authors: trudeau m. JAMA Oncol. 2022 Apr 1;8(4):597-606. doi: 10.1001/jamaoncol.2021.8049. JAMA Oncol. 2022. PMID: 35201264 Free PMC article.

2

Phase II study of weekly edatrexate as first-line chemotherapy for metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group study.

Vandenberg TA, Pritchard KI, Eisenhauer EA, Trudeau ME, Norris BD, Lopez P, Verma SS, Buckman RA, Muldal A. Vandenberg TA, et al. Among authors: trudeau me. J Clin Oncol. 1993 Jul;11(7):1241-4. doi: 10.1200/JCO.1993.11.7.1241. J Clin Oncol. 1993. PMID: 8315420 Clinical Trial.

3

Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada-Clinical Trials Group.

Trudeau ME, Eisenhauer EA, Higgins BP, Letendre F, Lofters WS, Norris BD, Vandenberg TA, Delorme F, Muldal AM. Trudeau ME, et al. J Clin Oncol. 1996 Feb;14(2):422-8. doi: 10.1200/JCO.1996.14.2.422. J Clin Oncol. 1996. PMID: 8636752 Clinical Trial.

4

Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicin.

Stewart DJ, Evans WK, Shepherd FA, Wilson KS, Pritchard KI, Trudeau ME, Wilson JJ, Martz K. Stewart DJ, et al. Among authors: trudeau me. J Clin Oncol. 1997 May;15(5):1897-905. doi: 10.1200/JCO.1997.15.5.1897. J Clin Oncol. 1997. PMID: 9164200 Clinical Trial.

5

Phase I-II studies of docetaxel as a single agent in the treatment of metastatic breast cancer.

Trudeau ME. Trudeau ME. Semin Oncol. 1999 Jun;26(3 Suppl 8):21-6. Semin Oncol. 1999. PMID: 10403470 Review.

6

Evaluation of HER-2/neu (erbB-2) status in breast cancer: from bench to bedside.

Hanna W, Kahn HJ, Trudeau M. Hanna W, et al. Among authors: trudeau m. Mod Pathol. 1999 Aug;12(8):827-34. Mod Pathol. 1999. PMID: 10463486 Review.

7

Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8.

Norris B, Pritchard KI, James K, Myles J, Bennett K, Marlin S, Skillings J, Findlay B, Vandenberg T, Goss P, Latreille J, Rudinskas L, Lofters W, Trudeau M, Osoba D, Rodgers A. Norris B, et al. Among authors: trudeau m. J Clin Oncol. 2000 Jun;18(12):2385-94. doi: 10.1200/JCO.2000.18.12.2385. J Clin Oncol. 2000. PMID: 10856098 Clinical Trial.

8

Optimizing adjuvant breast cancer chemotherapy: rationale for the MA.21 study.

Trudeau ME. Trudeau ME. Oncology (Williston Park). 2001 May;15(5 Suppl 7):7-13. Oncology (Williston Park). 2001. PMID: 11396366 Free article. Review.

9

Cost utility analysis of first-line hormonal therapy in advanced breast cancer: comparison of two aromatase inhibitors to tamoxifen.

Dranitsaris G, Verma S, Trudeau M. Dranitsaris G, et al. Among authors: trudeau m. Am J Clin Oncol. 2003 Jun;26(3):289-96. doi: 10.1097/01.COC.0000021042.55557.2B. Am J Clin Oncol. 2003. PMID: 12796603

10

Selection of adjuvant chemotherapy for treatment of node-positive breast cancer.

Trudeau M, Charbonneau F, Gelmon K, Laing K, Latreille J, Mackey J, McLeod D, Pritchard K, Provencher L, Verma S. Trudeau M, et al. Lancet Oncol. 2005 Nov;6(11):886-98. doi: 10.1016/S1470-2045(05)70424-1. Lancet Oncol. 2005. PMID: 16257797 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

472 results

Search Page

Filters